FDA Approves FIORICET WITH CODEINE — Actavis Pharma, Inc.
The FDA approved Actavis Pharma, Inc.'s application for the generic oral version of Fioricet With Codeine (butalbital, acetaminophen, caffeine, and codeine phosphate) on June 10, 2004, which is expected to intensify price pressure and erode market share for the brand-name product within the migraine analgesic market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day